ARTICLE | Management Tracks
Lambert becomes COO at Myriad
Plus: Remix, Cue and Siranomics
December 16, 2021 1:02 AM UTC
Myriad Genetics Inc. (NASDAQ:MYGN) promoted Nicole Lambert to COO. Lambert has held leadership roles for 20 years at the genetic testing and precision medicine company, most recently overseeing oncology, women’s health and international business units.
Remix Therapeutics Inc., which is developing small molecules to reprogram RNA processing, hired Zaven Kaprielian as CSO. Kaprielian was COO, project CSO of U.S. discovery and venture partner at Dementia Discovery Fund...